Painreform Net Income
| PRFX Stock | USD 3.34 0.38 12.84% |
As of the 19th of February, Painreform holds the Risk Adjusted Performance of (0.01), coefficient of variation of (4,405), and Variance of 56.38. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Painreform, as well as the relationship between them.
Painreform's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Painreform's valuation are provided below:We have found one hundred twenty available trending fundamental ratios for Painreform, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to check out all of Painreform recent market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 184.9 K in 2026. Enterprise Value is likely to drop to about (4.7 M) in 2026 This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. | Last Reported | Projected for Next Year | ||
| Net Loss | -7.9 M | -7.5 M | |
| Net Loss | -13.1 M | -12.5 M | |
| Net Loss | -13.1 M | -12.5 M | |
| Net Loss | (924.72) | (970.95) | |
| Net Income Per E B T | 1.15 | 1.31 |
Painreform | Net Income | Build AI portfolio with Painreform Stock |
The evolution of Net Income for Painreform provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Painreform compares to historical norms and industry peers.
Latest Painreform's Net Income Growth Pattern
Below is the plot of the Net Income of Painreform over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Painreform financial statement analysis. It represents the amount of money remaining after all of Painreform operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Painreform's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Painreform's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (14.59 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Painreform Net Income Regression Statistics
| Arithmetic Mean | (5,234,879) | |
| Coefficient Of Variation | (89.01) | |
| Mean Deviation | 4,019,137 | |
| Median | (2,090,000) | |
| Standard Deviation | 4,659,475 | |
| Sample Variance | 21.7T | |
| Range | 13.8M | |
| R-Value | (0.84) | |
| Mean Square Error | 6.7T | |
| R-Squared | 0.71 | |
| Significance | 0.000021 | |
| Slope | (778,251) | |
| Total Sum of Squares | 347.4T |
Painreform Net Income History
Other Fundumenentals of Painreform
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Painreform Net Income component correlations
Painreform Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Painreform is extremely important. It helps to project a fair market value of Painreform Stock properly, considering its historical fundamentals such as Net Income. Since Painreform's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Painreform's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Painreform's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Painreform. Anticipated expansion of Painreform directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Painreform assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate Painreform using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Painreform's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Painreform's market price to deviate significantly from intrinsic value.
It's important to distinguish between Painreform's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Painreform should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Painreform's market price signifies the transaction level at which participants voluntarily complete trades.
Painreform 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Painreform's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Painreform.
| 11/21/2025 |
| 02/19/2026 |
If you would invest 0.00 in Painreform on November 21, 2025 and sell it all today you would earn a total of 0.00 from holding Painreform or generate 0.0% return on investment in Painreform over 90 days. Painreform is related to or competes with Universe Pharmaceuticals, Elevai Labs, Dermata Therapeutics, Psyence Biomedical, Avenue Therapeutics, Virax Biolabs, and NewcelX. PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that prov... More
Painreform Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Painreform's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Painreform upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 52.96 | |||
| Value At Risk | (9.06) | |||
| Potential Upside | 10.36 |
Painreform Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Painreform's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Painreform's standard deviation. In reality, there are many statistical measures that can use Painreform historical prices to predict the future Painreform's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.09) | |||
| Total Risk Alpha | (0.53) | |||
| Treynor Ratio | 0.0768 |
Painreform February 19, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | 0.0868 | |||
| Mean Deviation | 4.94 | |||
| Coefficient Of Variation | (4,405) | |||
| Standard Deviation | 7.51 | |||
| Variance | 56.38 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.09) | |||
| Total Risk Alpha | (0.53) | |||
| Treynor Ratio | 0.0768 | |||
| Maximum Drawdown | 52.96 | |||
| Value At Risk | (9.06) | |||
| Potential Upside | 10.36 | |||
| Skewness | 2.1 | |||
| Kurtosis | 9.41 |
Painreform Backtested Returns
Painreform maintains Sharpe Ratio (i.e., Efficiency) of -0.0217, which implies the firm had a -0.0217 % return per unit of risk over the last 3 months. Painreform exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Painreform's Risk Adjusted Performance of (0.01), coefficient of variation of (4,405), and Variance of 56.38 to confirm the risk estimate we provide. The company holds a Beta of -2.35, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Painreform are expected to decrease by larger amounts. On the other hand, during market turmoil, Painreform is expected to outperform it. At this point, Painreform has a negative expected return of -0.17%. Please make sure to check Painreform's standard deviation, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if Painreform performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.67 |
Good predictability
Painreform has good predictability. Overlapping area represents the amount of predictability between Painreform time series from 21st of November 2025 to 5th of January 2026 and 5th of January 2026 to 19th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Painreform price movement. The serial correlation of 0.67 indicates that around 67.0% of current Painreform price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.67 | |
| Spearman Rank Test | 0.34 | |
| Residual Average | 0.0 | |
| Price Variance | 0.43 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Painreform reported net income of (14.59 Million). This is 104.27% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 102.55% higher than that of the company.
Painreform Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Painreform's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Painreform could also be used in its relative valuation, which is a method of valuing Painreform by comparing valuation metrics of similar companies.Painreform is currently under evaluation in net income category among its peers.
Painreform ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Painreform's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Painreform's managers, analysts, and investors.Environmental | Governance | Social |
Painreform Institutional Holders
Institutional Holdings refers to the ownership stake in Painreform that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Painreform's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Painreform's value.| Shares | Justinvest Llc | 2025-06-30 | 13.7 K | Ubs Group Ag | 2025-06-30 | 6.1 K | Advisor Group Holdings, Inc. | 2025-06-30 | 193 | Sbi Securities Co Ltd | 2025-06-30 | 6.0 | Apollon Wealth Management, Llc | 2025-03-31 | 0.0 | Tower Research Capital Llc | 2025-06-30 | 0.0 | Barclays Plc | 2025-03-31 | 0.0 | Hrt Financial Llc | 2025-03-31 | 0.0 |
Painreform Fundamentals
| Return On Equity | -1.28 | ||||
| Return On Asset | -0.36 | ||||
| Current Valuation | (1.11 M) | ||||
| Shares Outstanding | 2.01 M | ||||
| Shares Owned By Insiders | 9.39 % | ||||
| Shares Owned By Institutions | 2.45 % | ||||
| Number Of Shares Shorted | 194.93 K | ||||
| Price To Book | 0.28 X | ||||
| EBITDA | (14.55 M) | ||||
| Net Income | (14.59 M) | ||||
| Cash And Equivalents | 13.85 M | ||||
| Cash Per Share | 1.30 X | ||||
| Total Debt | 45 K | ||||
| Current Ratio | 29.02 X | ||||
| Book Value Per Share | 4.19 X | ||||
| Cash Flow From Operations | (12.62 M) | ||||
| Short Ratio | 0.68 X | ||||
| Earnings Per Share | 29.90 X | ||||
| Target Price | 12.0 | ||||
| Beta | 0.55 | ||||
| Market Capitalization | 1.87 M | ||||
| Total Asset | 4.53 M | ||||
| Retained Earnings | (56.45 M) | ||||
| Working Capital | 1.99 M | ||||
| Net Asset | 4.53 M |
About Painreform Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Painreform's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Painreform using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Painreform based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Painreform Stock Analysis
When running Painreform's price analysis, check to measure Painreform's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Painreform is operating at the current time. Most of Painreform's value examination focuses on studying past and present price action to predict the probability of Painreform's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Painreform's price. Additionally, you may evaluate how the addition of Painreform to your portfolios can decrease your overall portfolio volatility.